299 related articles for article (PubMed ID: 11889652)
1. Neuroendocrine, immune, and local responses related to temporomandibular disorders.
Kopp S
J Orofac Pain; 2001; 15(1):9-28. PubMed ID: 11889652
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptides in the arthritic TMJ and symptoms and signs from the stomatognathic system with special consideration to rheumatoid arthritis.
Appelgren A; Appelgren B; Kopp S; Lundeberg T; Theodorsson E
J Orofac Pain; 1995; 9(3):215-25. PubMed ID: 8995921
[TBL] [Abstract][Full Text] [Related]
3. The influence of neuropeptides, serotonin, and interleukin 1beta on temporomandibular joint pain and inflammation.
Kopp S
J Oral Maxillofac Surg; 1998 Feb; 56(2):189-91. PubMed ID: 9461143
[TBL] [Abstract][Full Text] [Related]
4. A model for the study of experimentally induced temporomandibular arthritis in rats: the effect of human recombinant interleukin-1 alpha on neuropeptide-like immunoreactivity.
Carleson J; Alstergren P; Appelgren A; Appelgren B; Kopp S; Theodorsson E; Lundeberg T
J Orofac Pain; 1996; 10(1):9-14. PubMed ID: 8995911
[TBL] [Abstract][Full Text] [Related]
5. Temporomandibular joint pressure pain threshold is systemically modulated in rheumatoid arthritis.
Alstergren P; Fredriksson L; Kopp S
J Orofac Pain; 2008; 22(3):231-8. PubMed ID: 18780536
[TBL] [Abstract][Full Text] [Related]
6. Substance P-associated increase of intra-articular temperature and pain threshold in the arthritic TMJ.
Appelgren A; Appelgren B; Kopp S; Lundeberg T; Theodorsson E
J Orofac Pain; 1998; 12(2):101-7. PubMed ID: 9656887
[TBL] [Abstract][Full Text] [Related]
7. Effect of temporomandibular joint arthrocentesis on synovial fluid mediator level of tumor necrosis factor-alpha: implications for treatment outcome.
Emshoff R; Puffer P; Strobl H; Gassner R
Int J Oral Maxillofac Surg; 2000 Jun; 29(3):176-82. PubMed ID: 10970078
[TBL] [Abstract][Full Text] [Related]
8. TMJ pain in relation to circulating neuropeptide Y, serotonin, and interleukin-1 beta in rheumatoid arthritis.
Alstergren P; Ernberg M; Kopp S; Lundeberg T; Theodorsson E
J Orofac Pain; 1999; 13(1):49-55. PubMed ID: 10425968
[TBL] [Abstract][Full Text] [Related]
9. The role of peripheral 5HT2A and 5HT1A receptors on the orofacial formalin test in rats with persistent temporomandibular joint inflammation.
Okamoto K; Imbe H; Tashiro A; Kimura A; Donishi T; Tamai Y; Senba E
Neuroscience; 2005; 130(2):465-74. PubMed ID: 15664703
[TBL] [Abstract][Full Text] [Related]
10. Relationship of synovial tumor necrosis factor alpha and interleukin 6 to temporomandibular disorder.
Lee JK; Cho YS; Song SI
J Oral Maxillofac Surg; 2010 May; 68(5):1064-8. PubMed ID: 20031289
[TBL] [Abstract][Full Text] [Related]
11. Peripheral sympathetic component of the temporomandibular joint inflammatory pain in rats.
Rodrigues LL; Oliveira MC; Pelegrini-da-Silva A; de Arruda Veiga MC; Parada CA; Tambeli CH
J Pain; 2006 Dec; 7(12):929-36. PubMed ID: 17157779
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in inflammatory mediator concentrations in an adjuvant model of temporomandibular joint inflammation.
Spears R; Dees LA; Sapozhnikov M; Bellinger LL; Hutchins B
J Orofac Pain; 2005; 19(1):34-40. PubMed ID: 15779537
[TBL] [Abstract][Full Text] [Related]
13. Clinical diagnosis of temporomandibular joint arthritis.
Alstergren P; Pigg M; Kopp S
J Oral Rehabil; 2018 Apr; 45(4):269-281. PubMed ID: 29392761
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain.
Nordahl S; Alstergren P; Kopp S
J Oral Maxillofac Surg; 2000 May; 58(5):525-30. PubMed ID: 10800908
[TBL] [Abstract][Full Text] [Related]
15. Insufficient endogenous control of tumor necrosis factor-alpha contributes to temporomandibular joint pain and tissue destruction in rheumatoid arthritis.
Alstergren P; Kopp S
J Rheumatol; 2006 Sep; 33(9):1734-9. PubMed ID: 16960936
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.
Kopp S; Alstergren P; Ernestam S; Nordahl S; Bratt J
Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364
[TBL] [Abstract][Full Text] [Related]
17. Temporomandibular joint pain and synovial fluid analysis: a review of the literature.
Bouloux GF
J Oral Maxillofac Surg; 2009 Nov; 67(11):2497-504. PubMed ID: 19837323
[TBL] [Abstract][Full Text] [Related]
18. Deficient cytokine control modulates temporomandibular joint pain in rheumatoid arthritis.
Ahmed N; Catrina AI; Alyamani AO; Mustafa H; Alstergren P
Eur J Oral Sci; 2015 Aug; 123(4):235-41. PubMed ID: 26010823
[TBL] [Abstract][Full Text] [Related]
19. Effects of adjuvant on neuropeptide-like immunoreactivity in the temporomandibular joint and trigeminal ganglia.
Carleson J; Bileviciute I; Theodorsson E; Appelgren B; Appelgren A; Yousef N; Kopp S; Lundeberg T
J Orofac Pain; 1997; 11(3):195-9. PubMed ID: 9610308
[TBL] [Abstract][Full Text] [Related]
20. 5-HT induces temporomandibular joint nociception in rats through the local release of inflammatory mediators and activation of local β adrenoceptors.
Oliveira-Fusaro MC; Clemente-Napimoga JT; Teixeira JM; Torres-Chávez KE; Parada CA; Tambeli CH
Pharmacol Biochem Behav; 2012 Sep; 102(3):458-64. PubMed ID: 22683622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
